Today's full card. A new one each day, with no account. The other cards stay the short version.
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Bottom lineA $1,000 stake in Amgen 15 years ago would now be worth over $8,000, underscoring the impact of sustained, above‑market returns.
Two ways to read it
Same story — hours-to-days context vs months ahead.
Over the next few weeks, watch for any quarterly earnings releases or FDA decisions that could shift Amgen’s valuation. Short‑term price swings may reflect market sentiment rather than fundamental changes, so a long‑term view is advisable.
For investors looking at multi‑year horizons, Amgen’s track record suggests it could remain a solid component of a growth‑oriented equity allocation. The company’s consistent outperformance may justify a higher weighting in a diversified portfolio.
What happened
Amgen (NASDAQ: AMGN) has delivered an average annual return of 14.83% over the past 15 years, outperforming the market by 2.06% on an annualized basis. A $1,000 investment in AMGN 15 years ago would be worth $8,020.52 today, based on a current price of $485.75.
Why it matters
The story highlights the power of compound growth and shows how a single company’s performance can significantly outpace the broader market over a long period. It provides a concrete example of the potential upside from long‑term equity holding.
How it affects you
Investors can use this data point to assess Amgen’s historical risk‑return profile and consider its fit within a diversified portfolio. The comparison to market returns may influence allocation decisions toward high‑growth biotech names.
Read the article
Source text we received with this story — expand to read it here, or open the publisher page.